Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Resistance training can help you preserve and enhance your muscles
A 2024 study comparing tirzepatide to semaglutide found that people taking tirzepatide lost significantly more weight than those taking semaglutide
Gradual dose titration, close A1c monitoring, and baseline/ongoing eye exams matter
The evidence for GLP-1 medications in treating NASH (the more severe form of fatty liver disease) is particularly impressive: Liraglutide achieved histological resolution of steatohepatitis in 39% of cases after 48 weeks, compared to just 9% in placebo groups 20 Patients taking liraglutide had 4.5 times higher likelihood of NASH resolution than those on placebo 20 Semaglutide demonstrated NASH resolution in 59% of participants versus 17% in placebo groups 21 We offer FibroScan technology to measure liver stiffness and fat content, helping us monitor your progress while on GLP-1 therapy
Endocr Pract 26:10739
US$ 25.43
US$ 20.01
US$ 20.62
US$ 23.73
